Association between tumor necrosis factor-α gene polymorphism and sasang constitution in cerebral infarction

American Journal of Chinese Medicine

Volumn 33, Issue 4, 2005, Pages 547-557

  Um, Jae Young ^a   Lee, Jae Heung ^b   Joo, Jong Cheon ^b   Kim, Kyung Yo ^b   Lee, Eun Hee ^c   Shin, Taekyun ^d   Hong, Seung Heon ^b   Kim, Hyung Min ^a  

^a Kyung Hee University   (South Korea)

^b Wonkwang University   (South Korea)

^c Jeonbuk Science College   (South Korea)

^d Jeju National University   (South Korea)

Author keywords

Cerebral infarction (CI); Gene; Polymorphism; Sasang constitution; Tumor necrosis factor (TNF )

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BRAIN INFARCTION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE PREDISPOSITION; FEMALE; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; PROMOTER REGION; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; TRADITIONAL MEDICINE;

ADULT; AGED; AGED, 80 AND OVER; BODY CONSTITUTION; CEREBRAL INFARCTION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; KOREA; MALE; MEDICINE, ORIENTAL TRADITIONAL; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); TUMOR NECROSIS FACTOR-ALPHA;

EID: 23944445071     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X05003156     Document Type: Article

References (32)

1. Andreotti, F., I. Porto, F. Crea and A. Maseri. Inflammatory gene polymorphisms and ischaemic heart disease: Review of population association studies. Heart 87: 107-112, 2002.
2. Barone, F.C., B. Arvin, R.F. White, A. Miller, C.L. Webb, R.N. Willette, P.G. Lysko and G.Z. Feuerstein. Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke 28: 1233-1244, 1997.
3. Braun, N., U. Michel, B.P. Ernst, R. Metzner, A. Bitsch, F. Weber and P. Rieckmann. Gene polymorphism at position -308 of the tumor necrosis factor-alpha (TNF-alpha) in multiple sclerosis and its influence on the regulation of TNF-alpha production. Neurosci. Lett. 215: 75-78, 1996.
4. Bruce, A.J., W. Boling, M.S. Kindy, J. Peschon, P.J. Kraemer, M.K. Carpenter, F.W. Holtsberg and M.P. Mattson. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat. Med. 2: 788-794, 1996.
5. Cabrera, M., M.A. Shaw, C. Sharples, H. Williams, M. Castes, J. Convit and J.M. Blackwell. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J. Exp. Med. 182: 1259-1264, 1995.
6. Cheng, B., S. Christakos and M.P. Mattson. Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis. Neuron 14: 139-153, 1994.
7. Clark, W.M. Cytokines and reperfusion injury. Neurology 49: S10-S14, 1997.
8. Collier, P.M., F. Wojnarowska, B. McGuire and K.I. Welsh. Polymorphism of tumor necrosis factor a promoter region of the MHC is strongly associated with linear IgA disease and affects prognosis. Br. J. Dermatol. 131: 22, 1994.
9. Dawson, D.A., D. Martin and J.M. Hallenbeck. Inhibition of tumor necrosis factor-alpha reduces focal cerebral ischemic injury in the spontaneously hypertensive rat. Neurosci. Lett. 218: 41-44, 1996.
10. Elneihoum, A.M., P. Falke, B. Hedblad, F. Lindgarde and K. Ohlsson. Leukocyte activation in atherosclerosis: Correlation with risk factors. Atherosclerosis 131: 79-84, 1997.
11. Gary, D.S., A.J. Bruce-Keller, M.S. Kindy and M.P. Mattson. Ischemic and excitotoxic brain injury is enhanced in mice lacking the p55 tumor necrosis factor receptor. J. Cereb. Blood Flow Metab. 18: 1283-1287, 1998.
12. Joseph, K.K. Compass of Health: Using the Art of Sasang Medicine to Maximize your Health. The Career Press, USA, 2001.
13. Lavine, S.D., F.M. Hofman and B.V. Zlokovic. Circulating antibody against tumor necrosis factor-alpha protects rat brain from reperfusion injury. J. Cereb. Blood Flow Metab. 18: 52-58, 1998.
14. Lee, J.M. Longevity and Life Preservation in Oriental Medicine. In: S.H. Choi (ed.) Kyung Hee University Press, Korea, 1996.
15. McGuire, W., A.V. Hill, C.E.M. Allsopp, B.M. Greenwood and D. Kwiatkowski. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 371: 508-510, 1994.
16. Miller, S.A., D.D. Dykes and H.F. Polesky. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16: 1215, 1988.
17. Nawashiro, H., D. Martin and J.M. Hallenbeck. Inhibition of tumor necrosis factor and amelioration of brain infarction in mice. J. Cereb. Blood Flow Metab. 17: 229-232, 1997a.
18. Nawashiro, H., D. Martin and J.M. Hallenbeck. Neuroprotective effects of TNF binding protein in focal cerebral ischemia. Brain Res. 778: 265-271, 1997b.
19. Nawashiro, H., K. Tasaki, C.A. Ruetzler and J.M. Hallenbeck. TNF-alpha pretreatment induces protective effects against focal cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 17: 483-490, 1997c.
20. Paleolog, E.M., S.A. Delasalle, W.A. Buurman and M. Feldmann. Functional activities of receptors for tumor necrosis factor-alpha on human vascular endothelial cells. Blood 84: 2578-2590, 1994.
21. Ross, R. Atherosclerosis: An inflammatory disease. N. Engl. J. Med. 340: 115-126, 1999.
22. Scherbel, U., R. Raghupathi, M. Nakamura, K.E. Saatman, J.Q. Trojanowski, E. Neugebauer, M.W. Marino and T.K. McIntosh. Differential acute and chronic responses of tumor necrosis factor-deficient mice to experimental brain injury. Proc. Natl. Acad. Sci. USA 96: 8721-8726, 1999.
23. Shohami, E., R. Bass, D. Wallach, A. Yamin and R. Gallily. Inhibition of tumor necrosis factor-alpha (TNF-alpha) activity in rat brain is associated with cerebroprotection after closed head injury. J. Cereb. Blood Flow Metab. 16: 378-384, 1996.
24. Shohami, E., I. Ginis and J.M. Hallenbeck. Dual role of tumor necrosis factor alpha in brain injury. Cytokine Growth Factor Rev. 10: 119-130, 1999.
25. Stoll, G., S. Jander and M. Schroeter. Inflammation and glial responses in ischemic brain lesions. Prog. Neurobiol. 56: 149-171, 1998.
26. Toborek, M., E.M. Blanc, S. Kaiser, M.P. Mattson and B. Hennig. Linoleic acid potentiates TNF-mediated oxidative stress, disruption of calcium homeostasis, and apoptosis of cultured vascular endothelial cells. J. Lipid. Res. 38: 2155-2167, 1997.
27. Wilson, A.G., F.E. Clay, A.M. Crane, M. Cork and G.W. Duff. Genetics of tumor necrosis factor alpha in dermatitis herpetiformis. J. Invest. Dermatol. 104: 856-858, 1995a.
28. Wilson, A.G., F.S. DiGiovine and G.W. Duff. Genetics of tumor necrosis factor-alpha in autoimmune, infectious, and neoplastic diseases. J. Inflamm. 45: 1-12, 1995b.
29. Wilson, A.G., J.A. Symons, T.L. McDowell, H.O. McDevitt and G.W. Duff. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc. Natl. Acad. Sci. USA 94: 3195-3199, 1997.
30. Woods, A., D.J. Brull, S.E. Humphries and H.E. Montgomery. Genetics of inflammation and risk of coronary artery disease: The central role of interleukin-6. Eur. Heart J. 21: 1574-1583, 2000.
31. Wu, W.S. and K.L. McClain. DNA polymorphisms and mutation of the tumor necrosis-alpha (TNF-alpha) promoter in Langerhans cell histiocytosis (LCH). J. Interferon Cytokine Res. 17: 631-635, 1997.
32. Yoshizumi, M., M.A. Perrella, J.C. Jr. Burnett and M.E. Lee. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ. Res. 73: 205-209, 1993.